LUPUS PANNICULITIS - A CASE REPORT WITH LONG-TERM FOLLOW-UP
Keywords:
lupus panniculitis, periorbital edema, discoid lupus erythematosus, hydroxychloroquineAbstract
Lupus erythematosus panniculitis (LEP), also known as lupus erythematosus profundus, is a rare subtype of chronic cutaneous lupus erythematosus (CCLE), characterized by inflammation of the subcutaneous adipose tissue. It is estimated to affect 1-3% of patients diagnosed with cutaneous lupus. It can present as a distinct clinical entity or in association with discoid lupus erythematosus (DLE) or systemic lupus erythematosus (SLE).
We report a case of lupus panniculitis with long-term follow-up in a 54-year-old woman, initially presenting with unilateral periorbital erythema and edema. The patient’s medical history revealed intermittent episodes of unilateral periorbital edema on the affected side over the previous three years along with the development of an erythematous, indurated lesion on the right cheek, which resolved with an atrophic, depressed plaque. During this period, the patient had been treated with oral antibiotics, corticosteroids, and antiviral therapy due to suspected clinical diagnoses of contact dermatitis, recurrent herpes simplex, and periorbital cellulitis. Considering the patient’s history, clinical presentation, histological evidence of lymphocytic lobular panniculitis, and immunological findings, a diagnosis of lupus panniculitis was established.
The patient demonstrated an excellent response to treatment with hydroxychloroquine and prednisolone, achieving complete resolution of her dermatological symptoms. However, after a three-year period without medical supervision and discontinuation of therapy, she presented with new lesions on the facial region, including one on the nose suspected to be DLE and multiple atrophic, depressed plaques on the upper arms.
References
Ng PP, Tan SH, Tan T. Lupus erythematosus panniculitis: a clinicopathologic study. Int J Dermatol 2002; 41(8): 488-490. doi: 10.1046/j.1365-4362.2002.01510.x.
Kaposi M. Pathologie und Therapie der Hautkrankheiten in Vorlesungen für praktische Ärzte und Studierende. 2nd ed. Wien: Urban & Schwarzenberg; 1883:642.
Irgang S. Lupus erythematosus profundus: Report of an example with clinical resemblance to Darier-Roussy sarcoid. Arch Derm Syphilol 1940; 42(1): 97-108. doi: 10.1001/archderm. 1940.01490130101012.
Massone C, Kodama K, Salmhofer W, Abe R, Shimizu H, Parodi A, et al. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases. J Cutan Pathol 2005; 32(6): 396-404. doi: 10.1111/j.0303-6987. 2005.00351.x.
Pérez-Pastor G, Valcuende F, Tomás G, Moreno M. Edema palpebral y parotiditis como forma de presentación de la paniculitis lúpica [Lupus erythematosus panniculitis presenting as palpebral edema and parotiditis]. Actas Dermosifiliogr 2007; 98(8): 549-552. https://doi.org/10.1016/S0001-7310(07)70131-X.
Zhao YK, Wang F, Chen WN, Xu R, Wang Z, Jiang YW, et al. Lupus Panniculitis as an Initial Manifestation of Systemic Lupus Erythematosus: A Case Report. Medicine (Baltimore) 2016; 95(16): e3429. doi: 10.1097/MD.0000000000003429.
Arai S, Katsuoka K. Clinical entity of Lupus erythematosus panniculitis/lupus erythematosus profundus. Autoimmun Rev 2009; 8(6): 449-452. doi: 10.1016/j.autrev.2008.12.011.
Magee KL, Hymes SR, Rapini RP, Yeakley JW, Jordon RE. Lupus erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol 1991; 24(2 Pt 1): 288-290. doi: 10.1016/s0190-9622(08)80610-x.
Minami-Hori M, Komatsu S, Komura K, Iizuka H, Ishida-Yamamoto A. Periorbital lupus profundus successfully treated with oral tacrolimus plus low-dose prednisolone. J Dermatol 2015; 42(2): 222-223. doi: 10.1111/1346-8138.12742.
Sheehan-Dare RA, Cunliffe WJ. Severe periorbital oedema in association with lupus erythematosus profundus. Clin Exp Dermatol 1988; 13(6): 406-407. doi: 10.1111/j.1365-2230.1988.tb00739.x.
Mullaaziz D, Maden S, Deren O, Özkayalar H. Periorbital lupus erythematosus profundus: A case report and review of the literature. Turkderm-Turk Arch Dermatol Venereol 2020; 54(3): 114-118. doi: 10.4274/turkderm.galenos.2020.32068.
Nowinski T, Bernardino V, Naidoff M, Parrish R. Ocular involvement in lupus erythematosus profundus (panniculitis). Ophthalmology 1982; 89(10): 1149-1154. doi: 10.1016/s0161-6420(82)34661-8.
Petrarolha SM, Rodrigues BS, Filho FD, Dedivitis RA, Petrarolha SB, Morais PM. Unilateral Eyelid Edema as Initial Sign of Orbital Sarcoidosis. Case Rep Ophthalmol Med 2016; 2016: 6912927. doi: 10.1155/2016/6912927.
Mahmood A, Mir R, Salama SR, Miarrostami RM, Lapidus C, Pujol F. Kikuchi's disease: an unusual presentation and a therapeutic challenge. Yale J Biol Med 2006; 79(1): 27-33. PMID: 17876373.
Aryasit O, Tiraset N, Preechawai P, Kayasut K, Sanghan N, Sittivarakul W. IgG4-related disease in patients with idiopathic orbital inflammation. BMC Ophthalmol 2021; 21(1): 356. doi: 10.1186/s12886-021-02115-x.
Castrillón MA, Murrell DF. Lupus profundus limited to a site of trauma: Case report and review of the literature. Int J Womens Dermatol 2017; 3(2): 117-120. doi: 10.1016/j. ijwd.2017.03.002.
Hosfiar VA, Rheza AM, Sirait SP, Fitri EM, Rihatmadja R, Novianto E. Lupus Erythematosus Panniculitis: Clinical and Histopathological Diagnostic Challenge. Proceedings of the 2nd International Conference on Tropical Medicine and Infectious Disease 2019; 272-276. doi: 10.5220/0009986402720276.
Patel RM, Marfatia YS. Lupus panniculitis as an initial manifestation of systemic lupus erythematosus. Indian J Dermatol 2010; 55(1): 99-101. doi: 10.4103/0019-5154.60364.
Braunstein I, Werth VP. Update on management of connective tissue panniculitides. Dermatol Ther 2012; 25(2): 173-182. doi: 10.1111/j.1529-8019.2012.01489.x.